Hruban RH, Canto MI, Goggins M, Schulick R, Klein AP (2010) Update on familial pancreatic cancer. Adv Surg 44:293–311

Article  PubMed  PubMed Central  Google Scholar 

Shindo K, Yu J, Suenaga M, Fesharakizadeh S, Cho C, Macgregor-Das A, Siddiqui A, Witmer PD, Tamura K, Song TJ, Navarro Almario JA, Brant A, Borges M, Ford M, Barkley T, He J, Weiss MJ, Wolfgang CL, Roberts NJ, Hruban RH, Klein AP, Goggins M (2017) Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma. J Clin Oncol 35(30):3382–3390. https://doi.org/10.1200/jco.2017.72.3502

Article  CAS  PubMed  PubMed Central  Google Scholar 

Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, Topazian M, Takahashi N, Fletcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee J, Tamm E, Vikram R, Bhosale P, Margolis D, Farrell J, Goggins M (2012) Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142(4):796–804 quiz e14-5. https://doi.org/10.1053/j.gastro.2012.01.005

Article  PubMed  Google Scholar 

Bipat S, Phoa SS, van Delden OM, Bossuyt PM, Gouma DJ, Lameris JS, Stoker J (2005) Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis. J Comput Assist Tomogr 29(4):438–445

Article  PubMed  Google Scholar 

Nawaz H, Fan CY, Kloke J, Khalid A, McGrath K, Landsittel D, Papachristou GI (2013) Performance characteristics of endoscopic ultrasound in the staging of pancreatic cancer: a meta-analysis. JOP 14(5):484–497. https://doi.org/10.6092/1590-8577/1512

Article  PubMed  Google Scholar 

Tamburrino D, Riviere D, Yaghoobi M, Davidson BR, Gurusamy KS (2016) Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. Cochrane Database Syst Rev 9(9):CD011515. https://doi.org/10.1002/14651858.CD011515.pub2

Article  PubMed  Google Scholar 

Rahman MIO, Chan BPH, Far PM, Mbuagbaw L, Thabane L, Yaghoobi M (2020) Endoscopic ultrasound versus computed tomography in determining the resectability of pancreatic cancer: a diagnostic test accuracy meta-analysis. Saudi J Gastroenterol 26(3):113–119. https://doi.org/10.4103/sjg.SJG_39_20

Article  PubMed  PubMed Central  Google Scholar 

Rijkers AP, Valkema R, Duivenvoorden HJ, van Eijck CHJ (2014) Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis. Eur J Surg Oncol (EJSO) 40(7):794–804. https://doi.org/10.1016/j.ejso.2014.03.016

Article  CAS  PubMed  Google Scholar 

Santhosh S, Mittal BR, Bhasin D, Srinivasan R, Rana S, Das A, Nada R, Bhattacharya A, Gupta R, Kapoor R (2013) Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics. J Gastroenterol Hepatol 28(2):255–261. https://doi.org/10.1111/jgh.12068

Article  CAS  PubMed  Google Scholar 

Seo S, Doi R, Machimoto T, Kami K, Masui T, Hatano E, Ogawa K, Higashi T, Uemoto S (2008) Contribution of 18F-fluorodeoxyglucose positron emission tomography to the diagnosis of early pancreatic carcinoma. J Hepatobiliary Pancreat Surg 15(6):634–639. https://doi.org/10.1007/s00534-007-1339-x

Article  PubMed  Google Scholar 

Matsumoto I, Shirakawa S, Shinzeki M, Asari S, Goto T, Ajiki T, Fukumoto T, Kitajima K, Ku Y (2013) 18-Fluorodeoxyglucose positron emission tomography does not aid in diagnosis of pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol 11(6):712–718. https://doi.org/10.1016/j.cgh.2012.12.033

Article  PubMed  Google Scholar 

Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB (1999) Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 131(4):247–255

Article  CAS  PubMed  Google Scholar 

Rulyak SJ, Brentnall TA (2001) Inherited pancreatic cancer: surveillance and treatment strategies for affected families. Pancreatology 1(5):477–485. https://doi.org/10.1159/000055851

Article  CAS  PubMed  Google Scholar 

Kimmey MB, Bronner MP, Byrd DR, Brentnall TA (2002) Screening and surveillance for hereditary pancreatic cancer. Gastrointest Endosc 56(4 Suppl):S82–S86

Article  PubMed  Google Scholar 

Canto MI, Goggins M, Yeo CJ, Griffin C, Axilbund JE, Brune K, Ali SZ, Jagannath S, Petersen GM, Fishman EK, Piantadosi S, Giardiello FM, Hruban RH (2004) Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2(7):606–621

Article  PubMed  Google Scholar 

Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM, Yeo C, Fishman EK, Brune K, Axilbund J, Griffin C, Ali S, Richman J, Jagannath S, Kantsevoy SV, Kalloo AN (2006) Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 4(6):766–781 quiz 665. https://doi.org/10.1016/j.cgh.2006.02.005

Article  PubMed  Google Scholar 

Canto MI, Almario JA, Schulick RD, Yeo CJ, Klein A, Blackford A, Shin EJ, Sanyal A, Yenokyan G, Lennon AM, Kamel IR, Fishman EK, Wolfgang C, Weiss M, Hruban RH, Goggins M (2018) Risk of neoplastic progression in individuals at high risk for pancreatic Cancer Undergoing Long-Term Surveillance. Gastroenterology 155(3):740–751e2. https://doi.org/10.1053/j.gastro.2018.05.035

Article  PubMed  Google Scholar 

Dbouk M, Katona BW, Brand RE, Chak A, Syngal S, Farrell JJ, Kastrinos F, Stoffel EM, Blackford AL, Rustgi AK, Dudley B, Lee LS, Chhoda A, Kwon R, Ginsberg GG, Klein AP, Kamel I, Hruban RH, He J, Shin EJ, Lennon AM, Canto MI, Goggins M (2022) The Multicenter Cancer of pancreas Screening Study: Impact on Stage and Survival. J Clin Oncol 40(28):3257–3266. https://doi.org/10.1200/JCO.22.00298

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klatte DCF, Boekestijn B, Wasser M, Feshtali Shahbazi S, Ibrahim IS, Mieog JSD, Luelmo SAC, Morreau H, Potjer TP, Inderson A, Boonstra JJ, Dekker FW, Vasen HFA, van Hooft JE, Bonsing BA, van Leerdam ME (2022) Pancreatic Cancer surveillance in carriers of a germline CDKN2A pathogenic variant: yield and outcomes of a 20-Year prospective Follow-Up. J Clin Oncol 40(28):3267–3277. https://doi.org/10.1200/JCO.22.00194

Article  CAS  PubMed  Google Scholar 

Overbeek KA, Levink IJM, Koopmann BDM, Harinck F, Konings I, Ausems M, Wagner A, Fockens P, van Eijck CH, Groot Koerkamp B, Busch ORC, Besselink MG, Bastiaansen BAJ, van Driel L, Erler NS, Vleggaar FP, Poley JW, Cahen DL, van Hooft JE, Bruno MJ (2022) Dutch Familial Pancreatic Cancer Surveillance Study G Long-term yield of pancreatic cancer surveillance in high-risk individuals. Gut 71(6):1152–1160. https://doi.org/10.1136/gutjnl-2020-323611

van Rijssen LB, Koerkamp BG, Zwart MJ, Bonsing BA, Bosscha K, van Dam RM, van Eijck CH, Gerhards MF, van der Harst E, de Hingh IH, de Jong KP, Kazemier G, Klaase J, van Laarhoven CJ, Molenaar IQ, Patijn GA, Rupert CG, van Santvoort HC, Scheepers JJ, van der Schelling GP, Busch OR, Besselink MG (2017) Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch pancreatic Cancer audit. HPB (Oxford) 19(10):919–926. https://doi.org/10.1016/j.hpb.2017.06.010

Article  PubMed  Google Scholar 

Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, Bassi C, Carrato A, Farrell J, Fishman EK, Fockens P, Gress TM, van Hooft JE, Hruban RH, Kastrinos F, Klein A, Lennon AM, Lucas A, Park W, Rustgi A, Simeone D, Stoffel E, Vasen HFA, Cahen DL, Canto MI, Bruno M (2020) Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the pancreas Screening (CAPS) Consortium. Gut 69(1):7–17. https://doi.org/10.1136/gutjnl-2019-319352. International Cancer of the Pancreas Screening c

Article  CAS  PubMed  Google Scholar 

Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW (2015) ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110(2):223–262 quiz 263. https://doi.org/10.1038/ajg.2014.435

Article  PubMed  PubMed Central  Google Scholar 

Sawhney MS, Calderwood AH, Thosani NC, Rebbeck TR, Wani S, Canto MI, Fishman DS, Golan T, Hidalgo M, Kwon RS, Riegert-Johnson DL, Sahani DV, Stoffel EM, Vollmer CM Jr., Qumseya BJ, Prepared by ASOPC (2022) ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations. Gastrointest Endosc 95(5):817–826. https://doi.org/10.1016/j.gie.2021.12.001

Article  PubMed  Google Scholar 

Aslanian HR, Lee JH, Canto MI (2020) AGA clinical practice update on Pancreas Cancer Screening in High-Risk individuals. Expert Rev Gastroenterol 159(1):358–362. https://doi.org/10.1053/j.gastro.2020.03.088

Article  CAS  Google Scholar 

Saftoiu A, Hassan C, Areia M, Bhutani MS, Bisschops R, Bories E, Cazacu IM, Dekker E, Deprez PH, Pereira SP, Senore C, Capocaccia R, Antonelli G, van Hooft J, Messmann H, Siersema PD, Dinis-Ribeiro M, Ponchon T (2020) Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) position Statement. Endoscopy 52(4):293–304. https://doi.org/10.1055/a-1104-5245

Article  PubMed  Google Scholar 

Tang S, Huang G, Liu J, Liu T, Treven L, Song S, Zhang C, Pan L, Zhang T (2011) Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: a meta-analysis. Eur J Radiol 78(1):142–150. https://doi.org/10.1016/j.ejrad.2009.09.026

Article  PubMed  Google Scholar 

DeWitt J, Devereaux B, Chriswell M, McGreevy K, Howard T, Imperiale TF, Ciaccia D, Lane KA, Maglinte D, Kopecky K, LeBlanc J, McHenry L, Madura J, Aisen A, Cramer H, Cummings O, Sherman S (2004) Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 141(10):753–763. https://doi.org/10.7326/0003-4819-141-10-200411160-00006

Article  PubMed  Google Scholar 

Dewitt J, Devereaux BM, Lehman GA, Sherman S, Imperiale TF (2006) Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol 4(6):717–725 quiz 664. https://doi.org/10.1016/j.cgh.2006.02.020

Article  PubMed  Google Scholar 

Muller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B (1994) Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology 190(3):745–751. https://doi.org/10.1148/radiology.190.3.8115622

Article  CAS  PubMed  Google Scholar 

Kann PH (2018) Is endoscopic ultrasonography more sensitive than magnetic resonance imaging in detecting and localizing pancreatic neuroendocrine tumors? Rev Endocr Metab Disord 19(2):133–137. https://doi.org/10.1007/s11154-018-9464-1

Article  CAS  PubMed